Global Arthroscopy Devices Market Size study & Forecast, by Type (Arthroscopes, Arthroscopic Implants, Fluid management systems, Radiofrequency systems, Visualization systems, Powered Shavers, Others) by Application (Knee Arthroscopy, Hip arthroscopy, Sho

Global Arthroscopy Devices Market Size study & Forecast, by Type (Arthroscopes, Arthroscopic Implants, Fluid management systems, Radiofrequency systems, Visualization systems, Powered Shavers, Others) by Application (Knee Arthroscopy, Hip arthroscopy, Shoulder and elbow arthroscopy, Others), and Regional Analysis, 2023-2030

Global Arthroscopy Devices Market is valued approximately at USD 34.6 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2023-2030. Arthroscopy Device is used to see, inspect, and perform therapeutic treatments inside the joints of the body, such as the knee, hip, spine, shoulder and elbow. The market for arthroscopic devices is predicted to expand because to an increase in the number of sports injuries when arthroscopy surgery may be used to avoid total joint replacements. One of the key causes boosting arthroscopic equipment sales is the rising occurrence of bone-related and musculoskeletal problems. Furthermore, favorable reimbursement policies in developed countries like U.S, Germany, Japan, as well as growing medical tourism in developing countries for cost-effective treatments and improving healthcare infrastructure, are expected to drive worldwide market expansion.

Globally prevalent among the elderly, degenerative knee disease is becoming more common as the world's geriatric population grows. According to the World Health Organisation estimates that in February 2021, 28% of persons over 50 will report having knee discomfort due to degenerative knee disease. The pain is incapacitating in nature, and frequently a knee replacement surgery is the last and only option to treat it. Due to the rising incidence of sports injuries, particularly those sustained in contact sports, the need for knee arthroscopies is rising internationally. Throughout the projected period, arthroscopic implants are expected to maintain their dominance in the global arthroscopy devices market. Additionally, Expansion and modernization of healthcare infrastructure are important opportunities for the arthroscopy devices market also Technological advancements have made it possible to employ arthroscopy devices for a variety of bone and joint conditions. . However, the high cost of Arthroscopy Devices and lack of skilled professionals can stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Arthroscopy Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to chronic illnesses and orthopaedic conditions are becoming more common, especially among the area's ageing population. For instance, according to a February 2021 article from the Centres for Disease Control and Prevention, roughly three out of four Americans 65 and older and more than one in two Americans over the age of 18 are affected by musculoskeletal illnesses. The three most prevalent musculoskeletal diseases recorded, which result in yearly trips to doctors' offices, ERs, and hospitals, are arthritis, back pain, and trauma. Asia Pacific is expected to Fastest growing during the forecast period, owing to the growth of medical tourism in this region. Also, increasing patient pool will propel the growth rate of the arthroscopy devices market in this region.

Major market player included in this report are:
Arthrex, Inc.
Conmed Corporation
Henke Sass Wolf GmbH
Johnson & Johnson
Karl storz GmbH & Co. KG
Medtronic plc
Richard Wolf GmbH
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings, Inc.

Recent Developments in the Market:
 In February 2022, Formus Labs, The world's first automated 3D planner for joint replacement operations, announced a $5 million (USD) funding round and the public release of its orthopaedic surgery planning system, which gives doctors unparalleled visibility into the pre-operation planning process.
 In July 2021, Stryker announced today that the first balloon implant for arthroscopic treatment of major irreparable rotator cuff tears (MIRCTs)* has been approved by the FDA. In Space offers surgeons a new choice in their shoulder continuum of care, allowing them to better fulfil the demands of their patients.

Global Arthroscopy Devices Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Application, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Arthroscopes
Arthroscopic Implants
Fluid management systems
Radiofrequency systems
Visualization systems
Powered Shavers
Others

By Application:
Knee Arthroscopy
Hip arthroscopy
Shoulder and elbow arthroscopy
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Arthrex, Inc.
Conmed Corporation
Henke Sass Wolf GmbH
Johnson & Johnson
Karl storz GmbH & Co. KG
Medtronic plc
Richard Wolf GmbH
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.